首页 文献索引 SCI期刊 AI助手
条件筛选
相关性 最新发表 最早发表
全文 标题 期刊 作者
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
模糊 精准
{{tag.shortname||tag.name}}:{{getFilterLabel(field)}} Clear All
Lijun Su,Yixi Zhu,Xuebo Li et al. Lijun Su et al.
Recently, photodynamic therapy (PDT) has gained considerable attention as a promising therapeutic approach for the treatment of psoriasis. Unfortunately, the activation of high mobility group box 1 protein (HMGB1) by PDT triggers innate and...
Qingyu Ren,Xin Jiang,Yam Nath Paudel et al. Qingyu Ren et al.
Ethnopharmacological relevance: Parkinson's disease (PD) is the second most devastating age-related neurodegenerative diseases after Alzheimer diseases (AD) and is characterized by the loss of dopaminergic (DA) neurons in...
Yam Nath Paudel,Shafi Ullah Khan,Iekhsan Othman et al. Yam Nath Paudel et al.
Glycyrrhizin (GL) is a well-known pharmacological inhibitor of high mobility group box 1 (HMGB1) and is abundantly present in the licorice root (Glycyrrhiza radix). HMGB1 protein, a key mediator of neuroinflammation, has been implicated in ...
Hyewon Oh,Arom Choi,Nieun Seo et al. Hyewon Oh et al.
Post contrast-acute kidney injury (PC-AKI) is defined as the deterioration of renal function after administration of iodinated contrast media. HMGB1 is known to play an important role in the development of acute kidney injury. The purpose o...
Shifeng Zhou,Guodan Liu,Zhenxing Si et al. Shifeng Zhou et al.
Background: High mobility group box 1 (HMGB1) is increased in osteoarthritis (OA) tissue and chondrocytes stimulated with interleukin-1β (IL-1β). Suppression of HMGB1 expression is correlated with reduced inflammatory r...
Kai Le,Shanshan Wu,Enkhmurun Chibaatar et al. Kai Le et al.
Hippocampal dysfunction related to cognitive impairment and emotional disorders in young children and adolescents caused by neonatal hypoxic-ischemic brain injury (HIBI) has attracted increasing attention in recent years. Crosstalk between ...
Yam Nath Paudel,Efthalia Angelopoulou,Bridgette Semple et al. Yam Nath Paudel et al.
Glycyrrhizin (glycyrrhizic acid), a bioactive triterpenoid saponin constituent of Glycyrrhiza glabra, is a traditional medicine possessing a plethora of pharmacological anti-inflammatory, antioxidant, antimicrobial, and antiaging properties...
Ya-Jun Li,Lin Wang,Bei Zhang et al. Ya-Jun Li et al.
Objectives: It has been proven that extracellular HMGB1 is involved in progression of neurologic disorders, such as stroke, traumatic brain injury, meningitis and epilepsy. Glycyrrhizin (GL) is a direct inhibitor of HMGB1...
Gu Gong,Lei Xiang,Libang Yuan et al. Gu Gong et al.
Aim: Glycyrrhizin (GL) has been reported to protect against ischemia and reperfusion (I/R)-induced injury by inhibiting the cytokine activity of high mobility group box 1 (HMGB1). In the present study, the protective effe...
Jing Chen,Jing Zhang,Lin Xu et al. Jing Chen et al.
Objective: High mobility group box 1 protein (HMGB1) is expressed in atherosclerotic lesions. However, its role in vascular system is unknown. In this study, we explore whether the inhibition of HMGB1 attenuates neointima...
耗时 0.11236 秒,为您在 48223910 条记录里面共找到 11 篇文章 [XML]